A case of malignant eccrine spiradenoma metastatic to intramammary lymph node

Tanaka, Yūko; Bhunchet, Ekapot; Shibata, Toshikatsu

doi:10.1007/s12282-007-0023-y

Cited by 16 publications

(14 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Malignant transformation to eccrine spiradenoma is extremely rare and is characterized by features such as rapid increase in size, bleeding, change in color, and ulceration. [1,4,5] Our case showed most of the clinical features of a malignant lesion but showed benign histologic findings. The patient has completed one year of follow up without any local recurrence.…”

Section: Giant Eccrine Spiradenoma Mimicking a Malignant Tumormentioning

confidence: 65%

“…Miconazole has been the most frequently reported contact sensitizer. [2][3][4][5][6][7][8] Raulin and Frosch [8] noted patch test positivity to miconazole in six of nine patients with imidazole contact allergy, while only three patients each showed positivity to clotrimazole, econazole, and isoconazole. Dooms-Goossens et al [7] also noted 51 (54%) patch test positive reactions to miconazole in 94 tested cases of suspected imidazole contact sensitivity.…”

Section: Giant Eccrine Spiradenoma Mimicking a Malignant Tumormentioning

confidence: 99%

See 1 more Smart Citation

Giant eccrine spiradenoma mimicking a malignant tumor

Tripathy

Mishra

Baisakh

et al. 2015

Indian J Dermatol Venereol Leprol

View full text Add to dashboard Cite

Section: Giant Eccrine Spiradenoma Mimicking a Malignant Tumormentioning

confidence: 65%

Section: Giant Eccrine Spiradenoma Mimicking a Malignant Tumormentioning

confidence: 99%

Giant eccrine spiradenoma mimicking a malignant tumor

Tripathy

Mishra

Baisakh

et al. 2015

Indian J Dermatol Venereol Leprol

View full text Add to dashboard Cite

“…In fact, most intramammary metastases have similar histology of the tumor from which they originate, such as in the case of metastases from ovarian cancer that have intra-metastatic microcalcifications [4,14,16]. However, one can be mistaken in making the diagnosis of primitive breast cancer [17][18]. To overcome this problem, it is recommended to use immunohistochemistry to accurately differentiate primary cancers from metastases.…”

Section: Discussionmentioning

confidence: 99%

Breast Metastasis From a Non-small Cell Lung Cancer: A Case Report

Guerrouaz¹,

Samba²,

BenSghier³

et al. 2020

Cureus

View full text Add to dashboard Cite

Although primary breast cancer (BC) is the most frequent cancer in the world, their mammary metastases are rare. In this paper, we report the case of a 51-year-old male patient diagnosed with a mammary lump and an intracranial hypertension syndrome. Mammography showed the presence of an irregular opacity without microcalcifications. After a cytological and immunohistochemical examination, the breast biopsy showed an adenocarcinoma of pulmonary origin. Computed tomography (CT) scans of the cerebrum, cervicothoracic spine, and abdomen showed a right apical pulmonary tumor associated with Barety's lymphadenopathy, as well as the presence of a mass in the right breast and secondary brain lesions. The patient received total brain irradiation which resulted in a marked clinical improvement. Afterward, he was treated with six cycles of palliative chemotherapy based on carboplatin area under the curve (AUC) 6 and paclitaxel, 175 mg/m² every 21 days, with a good response. After two months, the patient presented with a progression and he was treated with second-line chemotherapy. However, after three chemotherapy courses, the disease rapidly progressed and the patient was altered which required his admission to the palliative care department. The patient died 40 days later. This case shows the poor prognostic survival outcomes in this population of patients.

show abstract

“…The characteristics of both tumors in all reported cases in the literature over the past 76 years are displayed in Table 1. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]…”

Section: Introductionmentioning

confidence: 99%

Spiradenoma of the breast and review of cases over 76-years

Dick

Sharma

2019

CRCP

View full text Add to dashboard Cite

Spiradenomas stem from eccrine and apocrine glands to form benign cutaneous tumors. When arising on the breast, nipple, and areola region, spiradenomas can be difficult to differentiate from more worrisome breast masses. This is particularly true in patients with a prior history of breast cancer. These tumors can be mimicked by a wide range of adnexal growths and play a role in syndromic conditions. We present a case of a 56-year-old female with a 20-year enlarging left lower inner quadrant breast mass reviewed on mammography which was later excised and histopathologically diagnosed as a spiradenoma. Spiradenomas can be challenging to diagnose as they can present with similar findings on inexpensive and non-invasive testing such as ultrasound and mammogram. While a biopsy is a definitive tool for diagnosis, this is contraindicated in some spiradenoma mimickers such as epidermal cysts complicating diagnosis. To our knowledge, there are only six case reports of breast spiradenomas. We have reviewed the histopathology of this case and summarized all cases of breast spiradenomas and their malignant counterpart spiradenocarcinomas available in the literature compiling their presentations and imaging findings.

show abstract

A case of malignant eccrine spiradenoma metastatic to intramammary lymph node

Cited by 16 publications

References 14 publications

Giant eccrine spiradenoma mimicking a malignant tumor

Giant eccrine spiradenoma mimicking a malignant tumor

Breast Metastasis From a Non-small Cell Lung Cancer: A Case Report

Spiradenoma of the breast and review of cases over 76-years

Contact Info

Product

Resources

About